FMP

FMP

Enter

CRTX - Cortexyme, Inc.

Financial Summary of Cortexyme, Inc.(CRTX), Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for

photo-url-https://financialmodelingprep.com/image-stock/CRTX.jpg

Cortexyme, Inc.

CRTX

NASDAQ

Inactive Equity

Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer's and other degenerative diseases. Its lead drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule gingipain inhibitor, which is in Phase II/III clinical trial for use in patients with mild to moderate Alzheimer's disease, as well as for the treatment of oral squamous cell carcinoma, periodontitis, and coronavirus infection. The company was incorporated in 2012 and is headquartered in South San Francisco, California.

1.95 USD

0.05000007 (2.56%)

About

ceo

Ms. Casey Lynch

sector

Healthcare

industry

Biotechnology

website

https://www.cortexyme.com

exchange

NASDAQ

Description

Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer's and other degenerative diseases. Its lead drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule gingipain inhibitor, which is in Phase II/III clinical trial for use in patients with mild to moderate Alzheimer's disease, as well as for the treatment of oral squamous cell carcinoma, periodontitis, and coronavirus infection. The company was incorporated in 2012 and is headquartered in South San Francisco, California.

CIK

0001662774

ISIN

US22053A1079

CUSIP

22053A107

Address

269 E Grand Ave

Phone

14159105717

Country

US

Employee

55

IPO Date

May 9, 2019

Summary

CIK

0001662774

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

22053A107

ISIN

US22053A1079

Country

US

Price

1.95

Beta

1.4

Volume Avg.

0

Market Cap

70.45M

Shares

-

52-Week

-

DCF

4.32

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-0.66

P/B

-

Website

https://www.cortexyme.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest CRTX News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep